Literature DB >> 28572769

Corrigendum: Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.

Alejandro Romero1, Eva Ramos1, Paloma Patiño2, Maria J Oset-Gasque3, Francisco López-Muñoz4,5, José Marco-Contelles6, María I Ayuso7, Alberto Alcázar8.   

Abstract

[This corrects the article on p. 281 in vol. 8, PMID: 27932976.].

Entities:  

Keywords:  melatonin; neuroprotection; nitrones; oxidative stress; stroke

Year:  2017        PMID: 28572769      PMCID: PMC5447320          DOI: 10.3389/fnagi.2017.00159

Source DB:  PubMed          Journal:  Front Aging Neurosci        ISSN: 1663-4365            Impact factor:   5.750


María I. Ayuso and Alberto Alcázar were not included as authors in the published article. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. The authors apologize for this oversight. This error does not change the scientific conclusions of the article in any way.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  1 in total

1.  Synthesis, antioxidant properties and neuroprotection of α-phenyl-tert-butylnitrone derived HomoBisNitrones in in vitro and in vivo ischemia models.

Authors:  Beatriz Chamorro; Daniel Diez-Iriepa; Belén Merás-Sáiz; Mourad Chioua; David García-Vieira; Isabel Iriepa; Dimitra Hadjipavlou-Litina; Francisco López-Muñoz; Ricardo Martínez-Murillo; Daniel Gonzàlez-Nieto; Israel Fernández; José Marco-Contelles; María Jesús Oset-Gasque
Journal:  Sci Rep       Date:  2020-08-25       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.